Twins Face A Tough Bullpen Call On Cole Sands

As the Minnesota Twins weigh their options ahead of the November 20 deadline, the potential return of reliever Cole Sands hangs in the balance of a key medical evaluation.

The Twins have a fairly straightforward decision in front of them with Cole Sands: keep the door open, but don’t mistake that for a guarantee.

Minnesota faces a Nov. 20 tender deadline, and the case for bringing Sands back for 2027 starts with the price. MLB Trade Rumors projected his salary at $1.3 million, a figure that makes him a manageable gamble as the Twins try to reshape their bullpen. Tendering him would preserve the club’s rights while leaving the final salary to be worked out through an agreement or arbitration.

That doesn’t mean Sands is locked into a roster spot. It just means Minnesota would still control the conversation.

There’s reason to be interested in what he can still offer if the elbow cooperates. Sands was effective in 2024, putting up a 3.28 ERA and 1.00 WHIP over 71.1 innings while striking out 85 and walking only 12. Those numbers showed a reliever who could miss bats and avoid free passes, and at 29, he’s still young enough to make the Twins wonder whether better health could bring some of that back.

But the recent track record is less tidy. Sands finished 2025 with a 4.50 ERA and 64 strikeouts in 72 innings, then posted an 8.25 ERA in just 12 innings in 2026. That 2026 sample was too small to tell the whole story, but it also didn’t offer much comfort before the injury picture came into focus.

The medical side is the real hinge here. MLB listed a 2027 return after Sands had arthroscopic elbow surgery and a PRP injection on Aug.

  1. That’s a recovery estimate, not a clean bill of health.

The Twins need to know whether the elbow points toward a useful return before they commit to anything beyond a tender.

Still, the upside is enough to justify the conversation. Minnesota would be buying time on a pitcher who has already shown he can help, and the projected arbitration cost is modest enough to make that worthwhile as part of a larger bullpen rebuild. The club can keep Sands in the mix while continuing to add pitchers who are better positioned to handle important innings right away.

The risk is obvious, too. Even a relatively small salary takes up payroll space, and every roster spot matters. If the medical evaluation suggests a much worse outlook than the current recovery timeline, the argument for tendering him gets a lot thinner.

And the Twins shouldn’t treat this as if Sands is already penciled into the bullpen. The early Opening Day projection tied his role to both health and a contract tender, with several relief jobs still open. On top of that, the club’s realistic offseason plan called for two established relief additions, which would lessen the pressure to count on Sands immediately for high-leverage work.

If Minnesota does tender him, the next step is simple: let the pitcher prove it. The Twins should watch his command, his ability to finish hitters and how he bounces back between outings. His role should grow only if the stuff and the results come with it.

For now, tendering Sands makes sense as a calculated move. It keeps a possible contributor in the organization at a reasonable cost while the Twins keep building the bullpen around healthier, more dependable options.

In Other News...

Luis Arraez Suddenly Feels Like A Real Twins Reunion Possibility

With the offseason already taking shape around payroll questions and the uncertainty of collective bargaining talks, the Twins may be staring at a very different kind of winter than the one many expected. Owner Tom Pohlad has hinted the club could be willing to spend more, and that alone has reopened a door that once seemed shut: a possible reunion with former infielder Luis Arraez, whose bat still carries plenty of appeal for a team that knows exactly what he can bring.

Arraezs case is more interesting now than it would have been a year ago because his game has evolved beyond the contact-heavy profile Twins fans remember. He put together a strong offensive season in 2026 and also showed real progress defensively, which changes the conversation around how he might fit if Minnesota decides to get aggressive. A return would still depend on how the rest of the roster comes together, but the idea of Arraez back in a Twins uniform is suddenly hard to dismiss. [Read more 🡒]

Joe Ryan Just Became A Bigger Twins Offseason Decision

Joe Ryans offseason just got a little more complicated for the Twins, even if the basic answer remains the same: they still control him. Minnesota declined his $13 million mutual option for 2027, a move that shifts the conversation from a preset contract number to the arbitration process, while keeping him in the organization for one more year. For a pitcher who finished the 2026 season as a significant part of the rotation, it is the kind of decision that matters more for planning than for headlines.

What it does not do is hand the Twins extra flexibility or lock in a specific 2027 salary. Instead, it changes how that number gets determined, leaving both sides to navigate the next step of a relationship that still has plenty of value attached to it. For Minnesota, Ryan remains an important piece of the pitching picture, but the route to keeping him now looks a lot different than it did when the option was on the table. [Read more 🡒]

Twins Second Base Decision Could Define Their Offseason Priorities

Second base has a way of shaping the rest of an offseason, and for the Twins it looks like one of the clearest places where the front office may have to make a call. Kody Clemens was steadier at first base than he was at the keystone, which only adds to the sense that Minnesota could use an external answer there if it wants to tighten up the infield and add more offense at the same time.

Among the names being weighed, Brandon Lowe and Luis Arraez stand out for different reasons, with recent season performance and defensive value pushing the comparison in separate directions. Jim Bowdens contract projections only sharpen the debate, since Arraez is expected to cost more even though Lowe has been the more productive hitter lately, leaving the Twins to decide whether they want the safer fit, the better bat, or the one that makes the most financial sense. [Read more 🡒]